Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 10/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | DRD3 | P35462 | 2/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.37 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.37 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.37 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18976755 | 0.88 | DRD2 (0.39) | DRD2DRD3 | |
| SCHEMBL19538652 | 0.84 | GNAO1 (0.58) | KCNH2GNAI3GNAO1GNAI1 | |
| SCHEMBL26784070 | 0.83 | DRD2 (0.42) | DRD2ALDH1A1SMN1; SMN2GNAI3GNAO1 | |
| SCHEMBL5184021 | 0.82 | SMN1; SMN2 (0.42) | DRD2SMN1; SMN2DRD3KCNH2 | |
| SCHEMBL5184024 | 0.82 | SMN1; SMN2 (0.42) | DRD2SMN1; SMN2DRD3KCNH2 | |
| SCHEMBL23434543 | 0.80 | DRD2 (0.40) | DRD2ALDH1A1SMN1; SMN2 | |
| SCHEMBL179383 | 0.80 | DRD2 (0.44) | DRD2GNAI3GNAO1GNAI1SLC6A4 | |
| SCHEMBL1473088 | 0.78 | KMT2A (0.46) | DRD2ALDH1A1SMN1; SMN2DRD3KCNH2 | |
| SCHEMBL597482 | 0.78 | ALOX15 (0.50) | DRD2DRD3KCNH2GNAI3GNAO1 | |
| SCHEMBL4182146 | 0.78 | DRD3 (0.37) | DRD2DRD3KCNH2SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023177700-A2 | C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER | ANIMA BIOTECH INC. (US) | 2023-09-21 | — | — | WO | disclosed |
| WO-2023171736-A1 | MEDICINE CONTAINING VITAMIN D DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF, USED IN COMBINATION WITH IMMUNOMODULATORY SUBSTANCE | 帝人ファーマ株式会社 | 2023-09-14 | — | — | WO | disclosed |